Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Technetium Tc 99m Sestamibi × Clear all
NCT03065218 2022-07-26

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Medstar Health Research Institute

Phase 4 Terminated
4 enrolled 5 charts
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT01925170 2014-08-19

Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Mayo Clinic

Phase NA Completed
1,638 enrolled 15 charts
Breast

Breast Neoplasms

NCT00620373 2014-08-01

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Mayo Clinic

Phase NA Completed
969 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡